GlassScriptPhysician profile
Elinor Schottstaedt
NPI 1528090826
$928.20
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $174 · 2021: $48.62 · 2022: $99.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $167.56 | 2019-2021 | |
| Glaxosmithkline, LLC. | $132.75 | 2019-2020 | |
| Mylan Specialty L.P. | $117.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.71 | 2019-2020 | |
| Intuitive Surgical, INC. | $99.24 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $83.71 | 2019-2020 | |
| Genentech USA, INC. | $62.28 | 2019 | |
| Jazz Pharmaceuticals INC. | $38.65 | 2019 | |
| Csl Behring | $29.07 | 2020 | |
| United Therapeutics Corporation | $19.05 | 2021 | |
| Circassia INC. | $16.89 | 2019 | |
| Harmony Biosciences LLC | $16.69 | 2020 | |
| Grifols USA, LLC | $14.20 | 2019 | |
| Electromed, INC. | $13.62 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elinor Schottstaedt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.